NEWS

Transparency Reporting Update: United Kingdom

11.28.17 | By Caroline Franco and Veronique Monjardet
Since 2016, Life Sciences companies that are members of the Association of the British Pharmaceutical industry (ABPI) have been required to disclose payments to British Healthcare Professionals (HCPs) and Healthcare Read more

Enhancing Transparency in Canadian Healthcare

11.15.17 | By Prianka Patel
On September 27, 2017, the Ontario Minister of Health, Eric Hoskins, introduced Bill 160: Strengthening Quality and Accountability for Patients Act 2017 to strengthen openness and transparency within the healthcare Read more

Transparency Reporting Update: Spain

10.24.17 | By Caroline Franco
For the second year, members of Farmaindustria, the National Trade Association of the Spanish-based pharmaceutical industry, have published transfers of value made to Spanish Healthcare Professionals (HCPs) and Healthcare Organizations Read more

Transparency Reporting Update: Germany

09.26.17 | By Caroline Franco and Veronique Monjardet
Since 2016, Life Sciences companies that are members of the voluntary German FSA (“Freiwillige Selbskontrolle für die Arzneimittelindustrie”)[1] have been required to disclose payments to German HCPs and HCOs. Now Read more

ComplianceWatch: Canada

08.09.17 | By Prianka Patel
Insights from PCC Canada and a Look at Innovative Medicines Canada’s Voluntary Reporting Framework “If you think compliance is expensive, think about non-compliance.” That was the provocative but true opening Read more

Sunshine Act Takes Effect in South Korea

08.01.17 | By Darren Jones and Jennifer Bang
As highlighted in our March 29th, 2017 blog post, the South Korean Ministry of Health and Welfare enacted the nation’s “Sunshine Act” on June 3rd, and consequently published a reporting Read more